PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

PCORI approves $225 million in funding for dozens of health research studies and related projects

Awards support generation and use of reliable patient-centered comparative clinical effectiveness research findings to improve health and health care decision making

PCORI approves $225 million in funding for dozens of health research studies and related projects
2023-11-28
(Press-News.org) WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical effectiveness research (CER) studies. By comparing various approaches to care, these studies will help fill evidence gaps related to maternal illness and death, adolescent mental health, delirium in older adults, cardiovascular disease and a range of other high-burden health conditions.

Four awards include support for large patient-centered CER studies in which community organizations and research institutions as coequal partners will tackle clinical and social factors that contribute to inequities in maternal morbidity and mortality.

“Evidence generated by PCORI-funded studies provides patients, clinicians and other health care decision makers trustworthy information to help them evaluate their options and make informed decisions, improving health and health care for people across the nation,” said PCORI Executive Director Nakela L. Cook, M.D., MPH. “These latest awards demonstrate PCORI’s ongoing commitment to funding important research addressing evidence gaps on key health issues, including the persistent and worsening crisis of maternal morbidity and mortality and the related alarming disparities.”

This latest round of PCORI funding awards also includes CER studies researching questions about how to optimally use brief interventions to prevent alcohol use among adolescents; ways to prevent delirium among hospitalized patients, a particular concern for older adults and their families; strategies to achieve better blood pressure control; and ways to enhance use of cancer screening and treatment of depression.

Several studies specifically aim to address questions about how to optimize use of therapies and care delivery approaches to achieve greater equity in care access and outcomes among historically underserved populations. Several will evaluate optimal approaches for use of telehealth, such as apps and remote care via video.

Recognizing that generating evidence is not the end of the process of improving outcomes, PCORI supports projects designed to assess and expand ways to promote the uptake of PCORI-funded CER findings in clinical practice. To that end, PCORI approved around $10 million for four implementation projects.

One focuses on enhancing shared decision making related to colorectal cancer screening among older adults and a second on shared decision making related to anesthesia options for patients undergoing hip fracture surgery. The third and fourth projects aim to accelerate the adoption of evidence-based approaches, one focused on treating PTSD and the other on monitoring cancer symptoms during outpatient treatment.

To further enhance the rigor and quality of patient-centered CER, PCORI also approved $4 million to fund four studies to improve methods for conducting CER and nearly $3 million for two studies that will strengthen the evidence base on engaging patients and other health care decision makers in designing and conducting CER.

“It takes rigorously designed and conducted research using evidence-based approaches to generate reliable results, which is why PCORI invests in studies focused on methodology and the science of engagement,” said Harv Feldman, M.D., MSCE, PCORI’s Deputy Executive Director for Patient-Centered Research Programs. “PCORI also recognizes the need for comparative clinical effectiveness research findings to reach those whom they can help the most, which is why the organization funds projects to proactively disseminate and implement useful evidence, so it can be adopted faster in every day clinical care.”

Details of all the newly funded studies and projects are available on PCORI’s website. All funding awards were approved pending a business and programmatic review by PCORI staff and the issuance of formal award contracts. With these latest awards, PCORI has invested more than $4.5 billion to fund patient-centered CER and support other projects.

 

About PCORI

The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.

 

END

[Attachments] See images for this press release:
PCORI approves $225 million in funding for dozens of health research studies and related projects PCORI approves $225 million in funding for dozens of health research studies and related projects 2 PCORI approves $225 million in funding for dozens of health research studies and related projects 3

ELSE PRESS RELEASES FROM THIS DATE:

Opioids vs. NSAIDS: which are safest and most effective for treating pain following surgery?

Opioids vs. NSAIDS: which are safest and most effective for treating pain following surgery?
2023-11-28
LOS ANGELES (November 28, 2023)—Thousands of adolescents and young adults have outpatient surgery every day and are sent home with pain medication. Although the need for medication is clear, the best way to treat the pain is not. A new study led by investigators at the University of Michigan and Children’s Hospital Los Angeles will compare two treatment regimens—one that uses a regimen of non-opioid medication and another that adds a low-dose opioid—to determine the safest and most effective way to treat pain in adolescents and young adults recovering from common outpatient surgeries. In the past, opioids ...

Slash-and-burn agriculture can increase forest biodiversity

Slash-and-burn agriculture can increase forest biodiversity
2023-11-28
The slash-and-burn agriculture practiced by many Indigenous societies across the world can actually have a positive impact on forests, according to a new study done in Belize.   Researchers found that in areas of the rainforest in which Indigenous farmers using slash-and-burn techniques created intermediate-sized farm patches – neither too small nor too large – there were increases in forest plant diversity.   This contradicts what had long been the standard view in the past, promoted by the ...

Researchers engineer a material that can perform different tasks depending on temperature

Researchers engineer a material that can perform different tasks depending on temperature
2023-11-28
CHAMPAIGN, Ill. — Researchers report that they have developed a new composite material designed to change behaviors depending on temperature in order to perform specific tasks. These materials are poised to be part of the next generation of autonomous robotics that will interact with the environment. The new study conducted by University of Illinois Urbana-Champaign civil and environmental engineering professor Shelly Zhang and graduate student Weichen Li, in collaboration with professor Tian Chen and graduate student Yue Wang from the University ...

MU fish ecologist’s research indicates need to conserve iconic migratory snook in Mexico

2023-11-28
Allison Pease grew up fascinated by river fish, spending countless summers in a mask beneath the surface of Texas creeks. Now a fish ecologist in the College of Agriculture, Food and Natural Resources at the University of Missouri, Pease is studying the common snook — an iconic game fish that has filled an important cultural, ecological and economic niche in Mexico for centuries. Her latest study focuses on this species’ migration patterns and the effects of proposed hydrodams on their population in southern Mexico. For the study, Pease traveled to the states of Tabasco and Chiapas, where she investigated the snook’s almost ...

Two biomedical sciences researchers named among world’s most highly cited scientists for 2023

Two biomedical sciences researchers named among world’s most highly cited scientists for 2023
2023-11-28
ATLANTA — Two leading researchers in the Institute for Biomedical Sciences at Georgia State University have been ranked in the top 1 percent worldwide by citations for their field and publication year in the Web of Science database, according to the Highly Cited Researchers 2023 list by Clarivate. The annual Highly Cited Researchers list has identified global research scientists and social scientists who have demonstrated significant and broad influence in their fields of research since 2001. The ...

NYU Abu Dhabi researchers develop first-of-its-kind woven material made entirely from flexible organic crystals

2023-11-28
Fast facts: Weaving is one of the oldest crafts known to humankind, with the earliest textiles dating back to about 5,000 years ago. Organic crystals, long thought to be stiff and brittle, are now known to have extraordinary elastic properties, revealing an unexplored new direction in materials science. Abu Dhabi, UAE, November 28, 2023: Applying simple, ancient weaving techniques to newly recognized properties of organic crystals, researchers with the Smart Materials Lab (SML) and the Center for Smart Engineering Materials (CSEM) at NYU Abu Dhabi (NYUAD) have, for the first time, developed a unique form of woven “textile.” These new fabric ...

St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia

St. Jude revealed functional targets of oncogenic HOXA9 in high-risk pediatric leukemia
2023-11-28
(MEMPHIS, Tenn. – November 28, 2023) Scientists at St. Jude Children’s Research Hospital comprehensively identified genes directly regulated by a protein associated with high-risk pediatric leukemias. High-risk leukemias, particularly MLL-rearranged (MLL-r) leukemia, often overexpress the homeodomain transcription factor HOXA9 protein, which cannot currently be targeted with drugs. This study provides a foundation for revealing the HOXA9 regulation network and finding novel drug targets downstream of HOXA9 that can form the basis of new treatments. The findings were published today in Nature Communications.    HOXA9 ...

Human rights are a low priority for many national climate change adaptation policies, new Concordia research finds

Human rights are a low priority for many national climate change adaptation policies, new Concordia research finds
2023-11-28
The link between human rights and climate change adaptation policy has not been a major source of discussion in national policies, according to a new Concordia-led study. Moreover, the researchers say the topic should play a bigger role in the upcoming COP28 conference, opening this week in Dubai. The paper was published in the journal Climate Policy. Assistant professor in Concordia’s Department of Geography, Planning and Environment Alexandra Lesnikowski co-authored the study with researchers from McGill University’s Faculty ...

Want school kids to eat more vegetables? Don’t forget about the power of potatoes on the plate

2023-11-28
A new study published in Nutrients illustrates how potatoes may play a beneficial role in encouraging school aged children to eat more vegetables. The Dietary Guidelines for Americans currently recommends children ages 3-18 consume between 2.5-3 cups of vegetables per day to meet their total vegetable goals. Yet, the average school-age child eats only about 1 cup daily. “That’s why we wanted to learn more about how school meal offerings may influence kids’ eating behavior and possibly encourage greater vegetable consumption,” explains principal ...

Repairing nerve cells after injury and in chronic disease

Repairing nerve cells after injury and in chronic disease
2023-11-28
LA JOLLA (November 28, 2023)—Each year in the United States there are more than 3 million cases of peripheral neuropathy, wherein nerves outside of the brain and spinal cord are damaged and cause pain and loss of feeling in the affected areas. Peripheral neuropathy can occur from diabetes, injury, genetically inherited disease, infection, and more. Salk scientists have now uncovered in mice a mechanism for repairing damaged nerves during peripheral neuropathy. They discovered that the protein Mitf helps turn on the repair function of specialized nervous system Schwann cells. The findings, published in Cell Reports ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] PCORI approves $225 million in funding for dozens of health research studies and related projects
Awards support generation and use of reliable patient-centered comparative clinical effectiveness research findings to improve health and health care decision making